Testing effectiveness (Phase 2)WithdrawnNCT04648189
What this trial is testing
Cetuxibab to Reduce Circulating Tumor Cells in Early Stage NSCLC
Who this might be right for
Lung CancerSurgeryCirculating Tumor Cell
The Netherlands Cancer Institute
Showing 20 of 0 results